Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome.
暂无分享,去创建一个
M. Saito | R. Weiss | K. Ikeda | S. D. Smith | H. Foster | Z. Wang | J. Latifpour | K. Nishi | Y. Wada
[1] M. Saito,et al. Experimental Diabetes Upregulates the Expression of Uretereral Endothelin Receptors , 1997, Peptides.
[2] S. Douglas,et al. Signal transduction mechanisms mediating the vascular actions of endothelin. , 1997, Journal of vascular research.
[3] M. Webb,et al. Inhibitors of endothelin , 1997, Medicinal research reviews.
[4] H. Hama,et al. Molecular pharmacology and pathophysiological significance of endothelin. , 1996, Japanese journal of pharmacology.
[5] M. Saito,et al. Characterization of endothelin receptors in streptozotocin-induced diabetic rat vas deferens. , 1996, Biochemical pharmacology.
[6] M. Saito,et al. Effect of experimental diabetes on rat prostate endothelin receptors. , 1996, European journal of pharmacology.
[7] Y. Oztürk,et al. Effects of experimental diabetes and insulin on smooth muscle functions. , 1996, Pharmacological reviews.
[8] R. Moriuchi,et al. Two subtypes of endothelin receptors and endothelin peptides are expressed in differential cell types of the rat placenta: in vitro receptor autoradiographic and in situ hybridization studies. , 1996, Endocrinology.
[9] M. Polokoff,et al. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.
[10] R. M. Weiss,et al. Reversibility of Diabetes- and Diuresis-Induced Alterations in Rat Bladder Dome Muscarinic Receptors , 1994, Diabetes.
[11] J. Huidobro-Toro,et al. Involvement of ETA receptors in the facilitation by endothelin‐1 of non‐adrenergic non‐cholinergic transmission in the rat urinary bladder , 1994, British journal of pharmacology.
[12] M. Lerner,et al. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. , 1993, The Journal of biological chemistry.
[13] Y. Matsuzawa,et al. Effect of endothelin 1 on ion transport in isolated rat colon. , 1993, Gastroenterology.
[14] Y. Urade,et al. ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. , 1993, European journal of pharmacology.
[15] E. Levin,et al. Insulin Stimulates Production and Secretion of Endothelin From Bovine Endothelial Cells , 1993, Diabetes.
[16] A. Traish,et al. Endothelin in the urinary bladder. II. Characterization of endothelin receptor subtypes. , 1992, The Journal of urology.
[17] A. Traish,et al. Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation. , 1992, The Journal of urology.
[18] F. Marumo,et al. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. , 1992, The Journal of clinical investigation.
[19] K. Andersson,et al. Endothelin-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: calcium dependence and phosphoinositide hydrolysis. , 1992, General pharmacology.
[20] F. Murad,et al. Interactions of endothelins and EDRF in bovine native endothelial cells: selective effects of endothelin-3. , 1992, The American journal of physiology.
[21] Y. Urade,et al. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. , 1992, Biochemical and biophysical research communications.
[22] R. Weiss,et al. Differential Regulation of Bladder β-Adrenergic and Muscarinic Cholinergic Receptors in Experimental Diabetes , 1991, Diabetes.
[23] H. Lodish,et al. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Jones,et al. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. , 1991, Biochemical and biophysical research communications.
[25] T. Sakurai,et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.
[26] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[27] K. Andersson,et al. Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. , 1990, Acta physiologica Scandinavica.
[28] D. Thibeault,et al. Tissue Specificity of Endothelin Binding Sites , 1990, Journal of Cardiovascular Pharmacology.
[29] M. Kuhar,et al. Methods in Neurotransmitter Receptor Analysis , 1990 .
[30] Y. Hirata,et al. Specific receptors for endothelin‐3 in cultured bovine endothelial cells and its cellular mechanism of action , 1990, FEBS letters.
[31] W. Nayler,et al. Streptozotocin‐induced diabetes reduces the density of [125I]‐endothelin‐binding sites in rat cardiac membranes , 1989, British journal of pharmacology.
[32] C. Maggi,et al. Potent contractile activity of endothelin on the human isolated urinary bladder , 1989, British journal of pharmacology.
[33] M. Yanagisawa,et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[35] J. Belis,et al. Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus. , 1986, The Journal of pharmacology and experimental therapeutics.
[36] G. Burnstock,et al. The smooth muscle of rat bladder in the early stages of streptozotocin-induced diabetes. , 1984, British journal of urology.
[37] M. Shani,et al. The nucleotide sequence of the rat cytoplasmic β–actin gene , 1983 .
[38] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[39] M. Ellenberg. Development of urinary bladder dysfunction in diabetes mellitus. , 1980, Annals of internal medicine.
[40] H. Rosenthal. A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.
[41] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[42] E. A. Martelli,et al. Elevated urinary excretion of endothelins in streptozotocin diabetic rats. , 1994, Life sciences.
[43] T. Hayama,et al. Endothelin antagonistic peptide derivatives with high selectivity for ETA receptors , 1993 .
[44] T. Fukami,et al. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.
[45] Hy. Lin. Cloning and function expression of human endothelin-1 receptor cDNA , 1991 .
[46] I. Miyamori,et al. Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. , 1991, Life sciences.
[47] R. Weiss,et al. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. , 1989, The Journal of pharmacology and experimental therapeutics.